You are here

Article Text

Article menu
Download PDFPDF
Commentary
Care of the older person
Personalised, patient-inclusive clinical medication reviews can reduce drug-related problems in older patients
  1. Michelle Acorn
  1. NP/Nursing, University of Toronto Lawrence S Bloomberg Faculty of Nursing, Toronto, Ontario, Canada
  1. Correspondence to Dr Michelle Acorn, NP/Nursing, University of Toronto Lawrence S Bloomberg Faculty of Nursing, Toronto, ON M5T 1P8, Canada; drnpmichellegray{at}gmail.com

https://doi.org/10.1136/ebnurs-2019-103162

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Verdoorn S, Kwint HF, Blom JW, et al. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: a randomised controlled trial (DREAMeR-study). PLoS Med 2019;16:e1002798. doi: 10.1371/journal.pmed.1002798.

    Implications for practice and research

    • Optimising personalised and tailored clinical medication reviews (CMRs) for older patients can reduce drug-related problems (DRPs) due to multimorbidity and polypharmacy.

    • An approach to the CMR guided by patient goals and preferences are beneficial to quality of life and well-being.

    Context

    A CMR is a structured, critical examination of a patient’s medications with the objective of reaching an agreement about treatment, optimising medicine impact, minimising medication-related issues and reducing waste. Limited evidence exists on the CMR intervention ability to improve patient outcomes. The DREAMeR study looks at polypharmacy in older persons who can benefit from a patient-centred CMR focusing on personal goals, …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.